Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Grace Maresh"'
Publikováno v:
Frontiers in Endocrinology, Vol 8 (2017)
Tumors evolve in complex and dynamic microenvironments that they rely on for sustained growth, invasion, and metastasis. Within this space, tumor cells and non-malignant cells are in frequent communication. One specific mode of communication that has
Externí odkaz:
https://doaj.org/article/785504bac7cb44a8a2efc685a26775fa
Autor:
Admire Matsika, Thomas McGann, Ryan Sullivan, Andy Wu, Claire M. Davies, Linh Hellmers, Grace Maresh, Lez J. Burke, Brittney S. Harrington, John W. Lumley, Li Li, Yonghua Sheng, Adam D. Ewing, Kate Bastick, Rohan Lourie, Mark N. Adams, Kuan Yau Wong, Xin Zhang, Michael A. McGuckin, Yaowu He, Shannon McChesney, Amy Broomfield, Bhuvana Srinivasan, Laurie Zhong, James S. Palmer, David A. Margolin, John D. Hooper
Publikováno v:
Oncogene. 39:219-233
Elevated CUB-domain containing protein 1 (CDCP1) is predictive of colorectal cancer (CRC) recurrence and poor patient survival. While CDCP1 expression identifies stem cell populations that mediate lung metastasis, mechanisms underlying the role of th
Publikováno v:
Translational Andrology and Urology. 8:S156-S165
Renal cell carcinoma (RCC) is the most common solid neoplasm of the adult kidney and has a high potential for developing metastatic spread. Approximately 25–30% of RCC patients have metastatic disease at presentation, and 30–40% of patients devel
Autor:
Hallie Baer, Jessica Simon, Lara McKean-Baste, Alicia N. Ray, Heather Green, Grace Maresh, Xin Zhang, David Marjolin, Jennifer Paruch, Li Li
Publikováno v:
Cancer Research. 82:1487-1487
Introduction: MicroRNAs (miRNAs) are short non-coding RNAs implicated in post-transcriptional regulation of gene expression. Abnormal expression of miRNAs in cancer is associated with enhanced tumorigenesis and metastatic potential. Our previous data
Autor:
Xin Zhang, Amita Bhattarai, Ravan Moret, Grace Maresh, Alicia Nicole Ray, David Woods, Rachel Graham, Maria Latis, Stephen Bardot, Li Li
Publikováno v:
Cancer Research. 82:3104-3104
Background: Renal cell carcinoma (RCC) is a highly heterogeneous and metastatic disease with a widely varying prognosis. RCC is the first solid tumor treated with immune checkpoint blockade and approved by the FDA for showing improvement of clinical
Autor:
Eric Laborde, Shams Halat, Michael P. Marino, Li Li, Xin Zhang, Linh Hellmers, Maria Latsis, M'Liss A. Hudson, Daniel Canter, Ravan Moret, Marc R. Matrana, Jessie Gills, Sunil Talwar, Grace Maresh, Maureen Shuh, John Nelson, Jakob Reiser, Stephen Bardot
Publikováno v:
Oncotarget
// Jessie Gills 1, * , Ravan Moret 2, * , Xin Zhang 2 , John Nelson 1 , Grace Maresh 2 , Linh Hellmers 2 , Daniel Canter 1 , M’Liss Hudson 1, 6 , Shams Halat 3 , Marc Matrana 4 , Michael P. Marino 5 , Jakob Reiser 5 , Maureen Shuh 2 , Eric Laborde
Autor:
David A. Margolin, Nathan Hite, Aaron L. Klinger, Xin Zhang, Linh Hellmers, Peter E. Miller, Grace Maresh, Li Li
Publikováno v:
Diseases of the Colon & Rectum. 61:698-705
Colorectal cancer is a leading cause of cancer-related death. Small animal models allow for the study of different metastatic patterns, but an optimal model for metastatic colorectal cancer has not been established.The purpose of this study was to de
Publikováno v:
Journal of the American College of Surgeons. 233:S59
Autor:
Grace Maresh, Glenda C. Gobe, Ravan Moret, Daniel Canter, Maria Latsis, Xin Zhang, Stephen Bardot, Sunil Talwar, Christudas Morais, Li Li, Marc R. Matrana
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Renal cell carcinoma (RCC) incidence is increasing, and metastatic disease effects up to 25% of RCC patients. Additionally, RCC has varying prognoses and therapy respons...
Autor:
Li Li, Xin Zhang, Grace Maresh, Neeha Mathew, Amita Bhattarai, Linh Hellmers, Henry Yip, Ravan Moret, Lara McKean Baste, Heather Green, Maria Latsis, Stephen Bardot, David Margolin
Publikováno v:
The Journal of Immunology. 204:241.26-241.26
To evaluate therapeutic efficacy of immune checkpoint blockade (ICB) and conventional chemotherapy in pre-clinical models, we developed humanized patient-derived orthotopic xenograft (PDOX) models for colorectal cancer (CRC) and renal cell carcinoma